Korro Bio CFO resigns; CEO takes interim CFO role

Korro Bio, Inc.

CFO Vineet Agarwal resigns effective Oct 17, 2025; will advise for 30 days.
CEO Dr. Ram Aiyar named interim CFO in addition to CEO duties, no extra compensation.
Separation benefits include 9 months base salary ($352,500), prorated FY2025 target bonus ($149,400), and extended option exercise through Mar 31, 2027.
Departure is not related to any disagreement with management.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.